Research Use Only. Sourced exclusively from APEX Pharma. Not for human consumption, medical use, diagnosis, or treatment.
Apex Pharma · Retatrutide
Buy Retaklik 40mg UK
Retaklik 40mg is Apex Pharma's retatrutide (LY3437943) research peptide — a synthetic triple-receptor agonist for GLP-1, GIP, and glucagon pathways. Independently verified to ≥99% purity by Janoshik Analytical. Every order ships with a tamper-evident hologram and batch-specific COA.
Strength
40mg
Compound
Retatrutide
Purity
≥99%
Format
Research Pen
Testing
Janoshik HPLC/MS
Delivery
Next Day UK
Third-Party COA
Every batch verified by Janoshik Analytical
Hologram Verified
Tamper-evident hologram + batch-code verification
Next Day UK
Royal Mail Tracked, discreet packaging
Official APEX Partner Live Verification
Each unit includes an authentic scratch-to-reveal holographic code. Enter your unique code at apexpharma.io/verify to confirm live authenticity and view the Certificate of Analysis for your current batch.
Retaklik 40mg Research Specifications
Innovation You Can Trust, Backed by Science
We believe uncompromising transparency is essential in peptide research. Through our official partnership with Apex Pharma, every pen represents the pinnacle of pharmaceutical-grade research engineering.
“I personally sent an Apex Retaklik pen to an independent laboratory to be blind tested. It came back exactly as it should — perfect purity, correct peptide sequencing, and precise dosage. This takes the grey out of the grey market, giving researchers the best research peptides available.”
MyReta Research Team
Verified Independent Verification
Official Apex Partnership
Direct partnership with Apex Pharma ensures direct supply custody, authentic formulation, and direct batch tracing.
No Grey Market Risk
Eliminating mystery suppliers, unverified batches, and uncertain concentrations. Rigorous lab verification guarantees pure chemical integrity.
Scratch Hologram Verification
Scratch the security hologram on your box and verify authentic batch records in real-time directly on Apex Pharma's live database.
Also Available — The Upgraded Formula
Retaklik 2.0 — 44mg
The next-generation combination formula: retatrutide + cagrilintide in a single pen. Higher total dose, dual-pathway research potential.
£180Latest Retatrutide & Retaklik Research Articles
Categories: Retatrutide • Retaklik • Reta
Retatrutide TRIUMPH Results: Phase 3 Weight-Loss & Diabetes Data (2026)
Retatrutide’s 2026 Phase 3 data explained simply: TRIUMPH-1 delivered 28.3% mean weight loss at 80 weeks (45.3% lost 30%+), TRANSCEND-T2D-1 cut HbA1c up to 1.94%, plus knee and sleep-apnoea results. Still investigational — research use only.
How to Inject Retaklik / Retatrutide: The No-Mess UK Guide (Pens vs Vials)
Retaklik pen vs retatrutide vial: a plain-English, occasionally funny UK guide to how injecting actually works, why pens skip the mess of reconstitution, and how standard Retaklik compares to Retaklik 2.0.
Retatrutide 40mg Pen UK: Doses, Pen Guide, Price & COA (2026)
What a retatrutide 40mg pen really is, what the 40mg buys you, how many doses it holds, how long it lasts, pen vs vial, a fair UK price, and how to check yours is genuine with a batch COA, hologram and unique batch code. Research use only.
How to Reconstitute Retatrutide: Step-by-Step UK Guide (2026)
A clear, step-by-step UK guide to reconstituting retatrutide for research: what you need, the exact mixing order, the swirl-don’t-shake rule, storage stability, troubleshooting, and a free calculator to do the maths. Research use only.
Retatrutide Weight Loss Results: What the Clinical Trials Actually Show (2026)
Retatrutide produced up to 24.2% mean weight loss in Eli Lilly’s Phase 2 trial — and it hadn’t plateaued. Here’s exactly what the clinical data shows, how it compares to semaglutide and tirzepatide, and the UK research context.
Retaklik vs Retatrutide: Are They the Same Thing? (UK Guide 2026)
Retaklik and retatrutide get used interchangeably, but they’re not the same word — and Retaklik 2.0 isn’t even pure retatrutide. Here’s the plain-English UK explainer on what each term means and what to check before you buy.
Retaklik 40mg — Frequently Asked Questions
What is Retaklik 40mg?
Retaklik 40mg is Apex Pharma's branded retatrutide (LY3437943) research peptide — a synthetic triple-receptor agonist acting on GLP-1, GIP, and glucagon receptors. Supplied strictly for laboratory and in vitro research use.
Is Retaklik 40mg the same as retatrutide?
Yes. Retaklik is a trade name used by Apex Pharma for retatrutide-based research peptides. The active compound is the same molecule — retatrutide.
What is the difference between Retaklik 40mg and Retaklik 2.0 44mg?
Retaklik 40mg contains retatrutide only. Retaklik 2.0 44mg combines retatrutide and cagrilintide for a higher total dose in a single pen, offering dual-pathway research potential.
How do I verify my Retaklik batch?
Every My Reta order includes a tamper-evident hologram. Check the batch code against the Janoshik Analytical report published on our COA page.
Can I buy Retaklik 40mg in the UK?
Yes. My Reta supplies Retaklik 40mg research peptides from the UK with next-day delivery. For laboratory and research use only — not for human consumption.